rs121918424
Variant names:
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_021957.4(GYS2):c.1447T>C(p.Ser483Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000069 in 1,448,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Consequence
GYS2
NM_021957.4 missense
NM_021957.4 missense
Scores
10
8
1
Clinical Significance
Conservation
PhyloP100: 9.25
Publications
3 publications found
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
GYS2 Gene-Disease associations (from GenCC):
- glycogen storage disorder due to hepatic glycogen synthase deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.941
PP5
Variant 12-21546446-A-G is Pathogenic according to our data. Variant chr12-21546446-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 16055.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS2 | NM_021957.4 | c.1447T>C | p.Ser483Pro | missense_variant | Exon 12 of 16 | ENST00000261195.3 | NP_068776.2 | |
GYS2 | XM_024448960.2 | c.1447T>C | p.Ser483Pro | missense_variant | Exon 12 of 17 | XP_024304728.1 | ||
GYS2 | XM_006719063.4 | c.1216T>C | p.Ser406Pro | missense_variant | Exon 11 of 15 | XP_006719126.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS2 | ENST00000261195.3 | c.1447T>C | p.Ser483Pro | missense_variant | Exon 12 of 16 | 1 | NM_021957.4 | ENSP00000261195.2 | ||
ENSG00000285854 | ENST00000647960.1 | n.*1449T>C | non_coding_transcript_exon_variant | Exon 19 of 23 | ENSP00000497202.1 | |||||
ENSG00000285854 | ENST00000647960.1 | n.*1449T>C | 3_prime_UTR_variant | Exon 19 of 23 | ENSP00000497202.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1448858Hom.: 0 Cov.: 26 AF XY: 0.00000139 AC XY: 1AN XY: 721420 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1448858
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
721420
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33216
American (AMR)
AF:
AC:
0
AN:
44418
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25940
East Asian (EAS)
AF:
AC:
0
AN:
39558
South Asian (SAS)
AF:
AC:
0
AN:
85248
European-Finnish (FIN)
AF:
AC:
0
AN:
53248
Middle Eastern (MID)
AF:
AC:
0
AN:
5740
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1101608
Other (OTH)
AF:
AC:
0
AN:
59882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Glycogen storage disorder due to hepatic glycogen synthase deficiency Pathogenic:1
Aug 01, 1998
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at L482 (P = 2e-04);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.